NDC 69536-0162-88: Plan B One-Step levonorgestrel 1.5 mg Tablet, 1 tablet
This is a package of 1 tablet of Plan B One-Step levonorgestrel 1.5 mg Tablet from Foundation Consumer Healthcare LLC, first listed with the FDA May 2018 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.
NDC database record
One package, one record: these facts belong to NDC 69536-162-88 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 69536 labeler · 162 product · 88 package
- Package marketed since
- May 10, 2018
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2027
- Billing quantity
- 1 EA per package
- Barcode (UPC)
- 0369536146195, 0369536162881
- FDA record last changed
- Nov 19, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
- GSN (GCN sequence number): 058193
- GCN: 23549
- GPI-14 (Medi-Span): 25400040000340
- HICL (First Databank): 007318
- AHFS class code: 68:12.00.00
- RxCUI (RxNorm): 483325
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
RxNorm drug class
This medicine belongs to the Progestin class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Nov 19, 2026
Clinical
Levonorgestrel is used to prevent pregnancy after unprotected sexual intercourse (sex without any method of birth control or with a birth control method that failed or was not used properly [e.g., a condom that slipped or broke or birth control pills that were not taken as scheduled]). Levonorgestrel should not be used to prevent pregnancy on a regular basis. This medication is to be used as an emergency contraceptive or backup in case regular birth control fails or is used incorrectly. Levonorgestrel is in a class of medications called progestins. It works by preventing the release of an egg...
Read the full MedlinePlus article ↗- Take it as soon as you can, within 72 hours (3 days) after unprotected sex. The sooner you take it, the better it works. Don’t wait.
- How soon do I need to take levonorgestrel emergency contraception?
- If you vomit within 2 hours of taking the tablet, call a healthcare professional. They can tell you whether you should repeat the dose.
- No. The tablets are a backup method only and are not as effective as regular birth control. They also don’t protect against HIV or other sexually transmitted infections.
Patient education
Drug interactions
Supplement & herbal interactions
Some supplements/herbs that may interact with Levonorgestrel — tap one for details:
Levonorgestrel may be associated with lower levels of 2 nutrients — worth a chat with your pharmacist, not a cause for alarm.
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 69536-0162-88 You're viewing this Main listing | 1 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 TABLET in 1 BLISTER PACK | 2018-05-10 | — | Active |
| 69536-0162-99 69536-162-99 | 1 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 TABLET in 1 BLISTER PACK | 2019-08-15 | — | Active |
Pack size FAQ
What quantity is in this package?
How does this package differ from NDC 69536-0162-99?
What NDC number is used to bill for this package of Plan B One-Step levonorgestrel 1.5 mg Tablet?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Option 2 1.5 mg 00113-2003-12 | L. | 1 tablet | $6.412 | — | Availability likely | — |
| Levonorgestrel 1.5 mg 00536-1433-63 | Rugby | 1 tablet | $6.412 | — | Availability likely | — |
| New Day 1.5 mg 16714-0809-01 | Northstar | 1 tablet | $6.412 | — | Availability likely | — |
| EContra One-Step 1.5 mg 50102-0211-13 | Afaxys | 3 tablets | $6.412 | — | Availability likely | — |
| My Choice TM 1.5 mg 62756-0720-60 | SUN | 1 tablet | $6.412 | — | Availability likely | — |
| My Way 1.5 mg 68180-0852-11 | Lupin | 1 tablet | $6.412 | — | Availability likely | — |
| Levonorgestrel 1.5 mg 69230-0333-32 | Camber | 1 tablet | $6.412 | — | Availability likely | — |
| Levonorgestrel 1.5 mg 70700-0164-06 | Xiromed | 1 tablet | $6.412 | — | Availability likely | — |
| Her Style 1.5 mg 50742-0352-01 | Ingenus | 1 tablet | $6.585 | — | FDA listed | — |
| Opcicon One-Step 1.5 mg 62756-0718-60 | Sun | 1 tablet | $6.797 | — | FDA listed | — |
| Levonorgestrel 1.5 mg 40032-0622-30 | Novel | 1 tablet | — | — | FDA listed | — |
| My Way 1.5 mg 43386-0622-30 | Lupin | 1 tablet | — | — | FDA listed | — |
| Plan B One-Step 1.5 mg 50090-5978-00 | A-S | 1 tablet | — | — | FDA listed | — |
| My Choice 1.5 mg 51660-0096-11 | OHM | 1 tablet | — | — | FDA listed | — |
| Levonorgestrel 1.5 mg 51660-0723-11 | Ohm | 1 tablet | — | — | FDA listed | — |
| Levonorgestrel 1.5 mg 51660-0999-11 | Ohm | 1 tablet | — | — | FDA listed | — |
| Fem Choice morning after 1.5 mg 58602-0712-28 | Aurohealth | 1 tablet | — | — | FDA listed | — |
| Athentia Next 1.5 mg 58602-0721-57 | Aurohealth | 1 tablet | — | — | FDA listed | — |
| Econ Morning After 1.5 mg 58602-0841-48 | Aurohealth | 3 tablets | — | — | FDA listed | — |
| After Banger 1.5 mg 58602-0891-57 | Aurohealth | 1 tablet | — | — | FDA listed | — |
| Ithappenz Morning After 1.5 mg 58602-0892-57 | Aurohealth | 1 tablet | — | — | FDA listed | — |
| Levonorgestrel Tablet, 1.5 mg 59556-0282-01 | Strides | 1 tablet | — | — | FDA listed | — |
| Optionelle 1.5 mg 59556-0286-01 | Strides | 1 tablet | — | — | FDA listed | — |
| Emergency Contraceptive 1.5 mg 59726-0138-01 | P | 1 tablet | — | — | Discontinued | — |
| AfterPlan 1.5 mg 62756-0723-60 | SUN | 1 tablet | — | — | FDA listed | — |
| AfterPill 1.5 mg 64122-0605-01 | Syzygy | 1 tablet | — | — | FDA listed | — |
| My Way 1.5 mg 68071-4294-01 | NuCare | 1 tablet | — | — | FDA listed | — |
| Aftera 1.5 mg 69536-0103-88 | Foundation | 1 tablet | — | — | FDA listed | — |
| Next Choice One Dose 1.5 mg 69536-0133-88 | Foundation | 1 tablet | — | — | FDA listed | — |
| Plan B One-Step 1.5 mg 69536-0146-19 | Foundation | 1 tablet | — | — | FDA listed | — |
| Plan B One-Step 1.5 mgthis 69536-0162-88 | Foundation | 1 tablet | — | — | FDA listed | — |
| Take Action 1.5 mg 69536-0200-88 | Foundation | 1 tablet | — | — | FDA listed | — |
| Morning After 1.5 mg/1.5mg 69953-0515-01 | Rapha | 1 mg | — | — | FDA listed | — |
| Morning After 1.5 mg/1.5mg 69953-0516-01 | Rapha | 1 mg | — | — | FDA listed | — |
| Morning After 1.5 mg/1.5mg 69953-0517-01 | Rapha | 1 mg | — | — | FDA listed | — |
| PostDay One-Step 1.5 mg/1.5mg 69953-0617-42 | Rapha | 1 mg | — | — | FDA listed | — |
| PostDay One-Step 1.5 mg/1.5mg 69953-0618-43 | Rapha | 1 mg | — | — | FDA listed | — |
| PostDay One-Step 1.5 mg/1.5mg 69953-0628-60 | Rapha | 1 mg | — | — | FDA listed | — |
| LEADER Emergency Contraceptive Levonorgestrel 1.5 mg 70000-0600-01 | Cardinal | 1 tablet | — | — | FDA listed | — |
| Levonorgestrel 1.5 mg 70000-0675-01 | LEADER/ | 1 tablet | — | — | FDA listed | — |
| My Choice TM 1.5 mg 71205-0120-01 | Proficient | 1 tablet | — | — | FDA listed | — |
| My Way 1.5 mg 71205-0361-01 | Proficient | 1 tablet | — | — | FDA listed | — |
| Levonorgestrel 1.5 mg 71713-0098-11 | Thirty | 1 tablet | — | — | FDA listed | — |
| Amazon Basic Care Levonorgestrel 1.5 mg 72288-0324-28 | Amazon.com | 1 tablet | — | — | FDA listed | — |
| SheWise 1.5 mg 72657-0108-11 | GLENMARK | 1 tablet | — | — | Discontinued | — |
| Levonorgestrel 1.5 mg 72657-0123-11 | GLENMARK | 1 tablet | — | — | FDA listed | — |
| Morning After Pill 1.5 mg 73436-2859-01 | Cadence | 1 tablet | — | — | FDA listed | — |
| Morning After Pill 1.5 mg 73436-8292-01 | Cadence | 1 tablet | — | — | FDA listed | — |
| Levonorgestrel 1.5 mg 73581-0217-01 | YYBA | 1 tablet | — | — | FDA listed | — |
| Levonorgestrel 1.5 mg 79929-0016-01 | Naari | 1 tablet | — | — | FDA listed | — |
| Restart 1.5 mg 80584-0103-01 | Winx | 1 tablet | — | — | FDA listed | — |
| Julie Morning After Pill 1.5 mg 82791-0002-01 | Julie | 1 tablet | — | — | FDA listed | — |
| Julie Morning After Pill 1.5 mg 82791-0003-01 | Julie | 1 tablet | — | — | FDA listed | — |
| Julie 1.5 mg 82791-0335-01 | Julie | 1 tablet | — | — | FDA listed | — |
| Julie 1.5 mg 82791-0532-01 | Julie | 1 tablet | — | — | FDA listed | — |
| Julie 1.5 mg 82791-0538-01 | Julie | 1 tablet | — | — | FDA listed | — |
| PostDay One-Step 1.5 mg 85506-0100-10 | Home | 1 tablet | — | — | FDA listed | — |
| Option 2 1.5 mg 00113-8099-12 | L. | 1 tablet | — | — | FDA listed | — |
| Levonorgestrel 1.5 mg 73581-0017-01 | YYBA | 1 tablet | — | — | FDA listed | — |
| Julie Morning After Pill 1.5 mg 82791-0004-01 | Julie | 1 tablet | — | — | FDA listed | — |
| My After Plan 1.5 mg 51660-0098-11 | OHM | 1 tablet | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
What it looks like
Where does this data come from?
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Levonorgestrel inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII EWQ57Q8I5X
Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII ETJ7Z6XBU4
Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
-
UNII O8232NY3SJ
A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
-
UNII 8I089SAH3T
A carbohydrate powder extracted from potatoes. It serves as a filler to add bulk and volume to the tablet or capsule, and as a disintegrant to help the medicine break apart and release its active ingredient in your body.
-
UNII 7SEV7J4R1U
A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
6 inactive ingredients listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Foundation Consumer Healthcare LLC labeler code 69536
- Aftera LEVONORGESTREL 1.5 mg Tablet NDC 69536-103-88
- Campho-Phenique Cold Sore Treatment CAMPHOR (SYNTHETIC) and PHENOL 10.8 g/100g; 4.7 g/100g Gel NDC 69536-108-23
- Campho-Phenique Antiseptic Camphor (synthetic) and Phenol 10.8 g/100g; 4.7 g/100g Gel NDC 69536-109-50
- Campho-Phenique Antiseptic CAMPHOR (SYNTHETIC) and PHENOL 10.8 mg/100mL; 4.7 mg/100mL Liquid NDC 69536-110-75
- Next Choice One Dose levonorgestrel 1.5 mg Tablet NDC 69536-133-88
- Plan B One-Step levonorgestrel 1.5 mg Tablet NDC 69536-146-19
- St. Joseph Low Dose Aspirin 81 mg Tablet, Film Coated NDC 69536-181-12
- Alavert Allergy LORATADINE 10 mg Tablet, Orally Disintegrating NDC 69536-190-60
- Alavert Allergy LORATADINE 10 mg Tablet, Orally Disintegrating NDC 69536-195-20
- Take Action levonorgestrel 1.5 mg Tablet NDC 69536-200-88
- Bronkaid Max EPHEDRINE SULFATE 25 mg Tablet, Coated NDC 69536-250-24
- St. Joseph Chewable Low Dose Aspirin 81 mg Tablet, Chewable NDC 69536-281-10
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Use for women to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control)
⏱️ Dosage and Administration ▾
Directions take as soon as possible within 72 hours (3 days) after unprotected sex. The sooner you take it the better it will work. if you vomit within 2 hours after taking the medication, call a healthcare professional to find out if you should repeat the dose
⚠️ Warnings ▾
Warnings Allergy alert Do not use if you have ever had an allergic reaction to levonorgestrel Sexually transmitted diseases (STDs) alert This product does not protect against HIV/AIDS or other STDs Do not use if you are already pregnant (because it will not work) for regular birth control Ask a doctor or pharmacist before use if you are taking efavirenz (HIV medication) or rifampin (tuberculosis treatment) or medication for seizures (epilepsy). These medications may reduce the effectiveness of levonorgestrel. When using this product you may have menstrual changes tiredness breast pain nausea headache vomiting lower stomach (abdominal) pain dizziness Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control center right away.
📦 Storage and Handling ▾
Other information read the instructions, warnings and enclosed product leaflet before use do not use if carton is open or tear strip is removed or blister seal is broken or missing store at 20-25°C (68-77°F)
🧪 Active Ingredient ▾
Active ingredient Levonorgestrel 1.5 mg
🧪 Inactive Ingredients ▾
Inactive ingredients colloidal silicon dioxide, corn starch, lactose monohydrate, magnesium stearate, potato starch, talc
🎯 Purpose ▾
Purpose Emergency contraceptive
📄 Do Not Use ▾
Do not use if you are already pregnant (because it will not work) for regular birth control
📄 Ask a Doctor or Pharmacist Before Use If ▾
Ask a doctor or pharmacist before use if you are taking efavirenz (HIV medication) or rifampin (tuberculosis treatment) or medication for seizures (epilepsy). These medications may reduce the effectiveness of levonorgestrel.
📄 When Using This Product ▾
When using this product you may have menstrual changes tiredness breast pain nausea headache vomiting lower stomach (abdominal) pain dizziness
📄 Keep Out of Reach of Children ▾
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control center right away.
📄 Questions or Comments ▾
Questions? Call 1-800-330-1271 or visit www.PlanBOneStep.com
📄 Package Label / Principal Display Panel ▾
PRINCIPAL DISPLAY PANEL - 1.5 mg Tablet Blister Pack Box - NDC 69536-162-88 NDC 69536-162-88 This item is electronically protected Plan B One-Step ® levonorgestrel 1.5 mg emergency contraceptive Reduces chance of pregnancy after unprotected sex. Not for regular birth control. One Tablet. One Step. 1 Tablet Levonorgestrel 1.5 mg PRINCIPAL DISPLAY PANEL - 1.5 mg Tablet Blister Pack Box - NDC 69536-162-88
PRINCIPAL DISPLAY PANEL - 1.5 mg Tablet Blister Pack Box - NDC 69536-146-19 FOR CLINIC USE ONLY. NOT FOR RETAIL SALE. NDC 69536-146-19 Plan B One-Step ® levonorgestrel 1.5 mg emergency contraceptive Reduces chance of pregnancy after unprotected sex. Not for regular birth control. One Tablet. One Step. 1 Tablet Levonorgestrel 1.5 mg PRINCIPAL DISPLAY PANEL - 1.5 mg Tablet Blister Pack Box - NDC 69536-146-19
Medicare Part D spend CMS · PART D · 2026 (Q1)
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |